Inhibition	O
of	O
RNA	B-protein
polymerase	I-protein
II	I-protein
transcription	O
in	O
human	B-cell_type
cells	I-cell_type
by	O
synthetic	O
DNA-binding	O
ligands	O
[	O
see	O
comments	O
]	O

Sequence-specific	O
DNA-binding	O
small	O
molecules	O
that	O
can	O
permeate	O
human	B-cell_type
cells	I-cell_type
potentially	O
could	O
regulate	O
transcription	O
of	O
specific	O
genes	O
.	O

Multiple	O
cellular	B-protein
DNA-binding	I-protein
transcription	I-protein
factors	I-protein
are	O
required	O
by	O
HIV	O
type	O
1	O
for	O
RNA	O
synthesis	O
.	O

Two	O
pyrrole-imidazole	O
polyamides	O
were	O
designed	O
to	O
bind	O
DNA	O
sequences	O
immediately	O
adjacent	O
to	O
binding	O
sites	O
for	O
the	O
transcription	B-protein
factors	I-protein
Ets-1	B-protein
,	O
lymphoid-enhancer	B-protein
binding	I-protein
factor	I-protein
1	I-protein
,	O
and	O
TATA-box	B-protein
binding	I-protein
protein	I-protein
.	O

These	O
synthetic	O
ligands	O
specifically	O
inhibit	O
DNA-binding	O
of	O
each	O
transcription	B-protein
factor	I-protein
and	O
HIV	O
type	O
1	O
transcription	O
in	O
cell-free	O
assays	O
.	O

When	O
used	O
in	O
combination	O
,	O
the	O
polyamides	O
inhibit	O
virus	O
replication	O
by	O
>	O
99	O
%	O
in	O
isolated	B-cell_type
human	I-cell_type
peripheral	I-cell_type
blood	I-cell_type
lymphocytes	I-cell_type
,	O
with	O
no	O
detectable	O
cell	O
toxicity	O
.	O

The	O
ability	O
of	O
small	O
molecules	O
to	O
target	O
predetermined	O
DNA	B-DNA
sequences	I-DNA
located	O
within	O
RNA	B-DNA
polymerase	I-DNA
II	I-DNA
promoters	I-DNA
suggests	O
a	O
general	O
approach	O
for	O
regulation	O
of	O
gene	O
expression	O
,	O
as	O
well	O
as	O
a	O
mechanism	O
for	O
the	O
inhibition	O
of	O
viral	O
replication	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

95	NULL
,	NULL
pp	NULL
.	NULL

12890-12895	NULL
,	NULL
October	NULL
1998	NULL
Biochemistry	NULL
Inhibition	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
transcription	NULL
in	NULL
human	NULL
cells	NULL
by	NULL
synthetic	NULL
DNA-binding	NULL
ligands	NULL
(	NULL
HIV	NULL
type	NULL
1	NULL
/viral	NULL
replication	NULL
/hairpin	NULL
polyamide/DNA	NULL
recognition	NULL
)	NULL
LILIaNE	NULL
A.	NULL
Dickinson*	NULL
,	NULL
RicHarp	NULL
J.	NULL
GuuizIat	NULL
,	NULL
Jonn	NULL
W.	NULL
TRaAUGER	NULL
$	NULL
,	NULL
ELDON	NULL
E.	NULL
BairD	NULL
#	NULL
,	NULL
DoNaALD	NULL
E.	NULL
MostERT	NULL
,	NULL
JoEL	NULL
M.	NULL
GoTrEsFELD*§	NULL
,	NULL
anp	NULL
PETER	NULL
B	NULL
.	NULL

Der	NULL
vant§	NULL
Departments	NULL
of	NULL
*Molecular	NULL
Biology	NULL
and	NULL
*Immunology	NULL
,	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
92037	NULL
;	NULL
and	NULL
Division	NULL
of	NULL
Chemistry	NULL
and	NULL
Chemical	NULL
Engineering	NULL
and	NULL
Beckman	NULL
Institute	NULL
,	NULL
California	NULL
Institute	NULL
of	NULL
Technology	NULL
,	NULL
Pasadena	NULL
,	NULL
CA	NULL
91125	NULL
Contributed	NULL
by	NULL
Peter	NULL
B.	NULL
Dervan	NULL
,	NULL
August	NULL
20	NULL
,	NULL
1998	NULL
ABSTRACT	NULL
Sequence-specific	NULL
DNA-binding	NULL
small	NULL
molecules	NULL
that	NULL
can	NULL
permeate	NULL
human	NULL
cells	NULL
potentially	NULL
could	NULL
regulate	NULL
transcription	NULL
of	NULL
specific	NULL
genes	NULL
.	NULL

Multiple	NULL
cellular	NULL
DNA-binding	NULL
transcription	NULL
factors	NULL
are	NULL
required	NULL
by	NULL
HIV	NULL
type	NULL
1	NULL
for	NULL
RNA	NULL
synthesis	NULL
.	NULL

Two	NULL
pyrrole-imidazole	NULL
polyamides	NULL
were	NULL
designed	NULL
to	NULL
bind	NULL
DNA	NULL
sequences	NULL
immediately	NULL
adjacent	NULL
to	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
transcription	NULL
factors	NULL
Ets-1	NULL
,	NULL
lymphoid-enhancer	NULL
binding	NULL
factor	NULL
1	NULL
,	NULL
and	NULL
TATA-box	NULL
binding	NULL
protein	NULL
.	NULL

These	NULL
synthetic	NULL
ligands	NULL
specifically	NULL
inhibit	NULL
DNA-binding	NULL
of	NULL
each	NULL
transcription	NULL
factor	NULL
and	NULL
HIV	NULL
type	NULL
1	NULL
transcription	NULL
in	NULL
cell-free	NULL
assays	NULL
.	NULL

When	NULL
used	NULL
in	NULL
combination	NULL
,	NULL
the	NULL
polyamides	NULL
inhibit	NULL
virus	NULL
replication	NULL
by	NULL
>	NULL
99	NULL
%	NULL
in	NULL
isolated	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
,	NULL
with	NULL
no	NULL
detectable	NULL
cell	NULL
toxicity	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
small	NULL
molecules	NULL
to	NULL
target	NULL
predetermined	NULL
DNA	NULL
sequences	NULL
located	NULL
within	NULL
RNA	NULL
polymerase	NULL
II	NULL
promoters	NULL
suggests	NULL
a	NULL
general	NULL
approach	NULL
for	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
mechanism	NULL
for	NULL
the	NULL
inhibition	NULL
of	NULL
viral	NULL
replication	NULL
.	NULL

Simple	NULL
rules	NULL
have	NULL
been	NULL
developed	NULL
to	NULL
rationally	NULL
control	NULL
the	NULL
sequence	NULL
specificity	NULL
of	NULL
minor-groove	NULL
binding	NULL
polyamides	NULL
containing	NULL
pyrrole	NULL
(	NULL
Py	NULL
)	NULL
and	NULL
imidazole	NULL
(	NULL
Im	NULL
)	NULL
amino	NULL
acids	NULL
(	NULL
1-6	NULL
)	NULL
.	NULL

DNA	NULL
recognition	NULL
depends	NULL
on	NULL
a	NULL
code	NULL
of	NULL
side-by-side	NULL
aromatic	NULL
amino	NULL
acid	NULL
pairings	NULL
in	NULL
the	NULL
minor	NULL
groove	NULL
.	NULL

A	NULL
pyrrole	NULL
opposite	NULL
an	NULL
imidazole	NULL
(	NULL
Py/Im	NULL
pairing	NULL
)	NULL
targets	NULL
a	NULL
C-G	NULL
bp	NULL
whereas	NULL
Im/Py	NULL
targets	NULL
a	NULL
G-C	NULL
bp	NULL
.	NULL

A	NULL
Py/Py	NULL
pair	NULL
binds	NULL
both	NULL
AT	NULL
and	NULL
T-A	NULL
pairs	NULL
.	NULL

These	NULL
compounds	NULL
represent	NULL
the	NULL
only	NULL
class	NULL
of	NULL
synthetic	NULL
small	NULL
molecules	NULL
that	NULL
can	NULL
bind	NULL
predetermined	NULL
DNA	NULL
sequences	NULL
with	NULL
affinities	NULL
and	NULL
specificities	NULL
comparable	NULL
to	NULL
DNA-binding	NULL
proteins	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
DNA-binding	NULL
activity	NULL
of	NULL
the	NULL
5S	NULL
RNA	NULL
gene-specific	NULL
transcription	NULL
factor	NULL
TFIIIA	NULL
was	NULL
inhibited	NULL
by	NULL
an	NULL
eight-ring	NULL
hairpin	NULL
polyamide	NULL
that	NULL
bound	NULL
within	NULL
the	NULL
recognition	NULL
site	NULL
of	NULL
zinc	NULL
finger	NULL
four	NULL
in	NULL
the	NULL
DNA	NULL
minor	NULL
groove	NULL
.	NULL

As	NULL
a	NULL
result	NULL
,	NULL
transcription	NULL
of	NULL
5S	NULL
RNA	NULL
genes	NULL
by	NULL
RNA	NULL
polymerase	NULL
III	NULL
was	NULL
suppressed	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
cultured	NULL
Xenopus	NULL
cells	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
question	NULL
arises	NULL
whether	NULL
polyamides	NULL
can	NULL
permeate	NULL
human	NULL
cells	NULL
and	NULL
specifically	NULL
regulate	NULL
genes	NULL
transcribed	NULL
by	NULL
pol	NULL
II	NULL
(	NULL
RNA	NULL
polymerase	NULL
II	NULL
)	NULL
.	NULL

As	NULL
a	NULL
first	NULL
case	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
polyamides	NULL
to	NULL
inhibit	NULL
HIV	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
transcription	NULL
in	NULL
cell-free	NULL
assays	NULL
and	NULL
viral	NULL
replication	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

The	NULL
HIV-1	NULL
enhancer/promoter	NULL
element	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
cell-encoded	NULL
proteins	NULL
upstream	NULL
stimulatory	NULL
factor	NULL
,	NULL
Ets-1	NULL
,	NULL
lymphoid-enhancer	NULL
binding	NULL
factor	NULL
1	NULL
(	NULL
LEF-1	NULL
)	NULL
the	NULL
nuclear	NULL
factors	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
Sp1	NULL
,	NULL
and	NULL
TATA-box	NULL
binding	NULL
protein	NULL
(	NULL
TBP	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
(	NULL
9	NULL
)	NULL
.	NULL

To	NULL
shut-down	NULL
the	NULL
promoter	NULL
,	NULL
polyamides	NULL
were	NULL
designed	NULL
to	NULL
target	NULL
the	NULL
transcription	NULL
factors	NULL
TBP	NULL
,	NULL
LEF-1	NULL
,	NULL
and	NULL
Ets-1	NULL
simultaneously	NULL
.	NULL

TBP	NULL
is	NULL
indispensable	NULL
for	NULL
initiation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
,	NULL
and	NULL
LEF-1	NULL
,	NULL
considered	NULL
to	NULL
be	NULL
an	NULL
architectural	NULL
protein	NULL
,	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
coordinating	NULL
activities	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
National	NULL
Academy	NULL
of	NULL
Sciences	NULL
0027-8424/98/9512890-6	NULL
$	NULL
2.00/0	NULL
PNAS	NULL
is	NULL
available	NULL
online	NULL
at	NULL
www.pnas.org	NULL
.	NULL

12890	NULL
of	NULL
multiple	NULL
transcription	NULL
factors	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Both	NULL
TBP	NULL
and	NULL
LEF-1	NULL
bind	NULL
the	NULL
minor	NULL
groove	NULL
of	NULL
DNA	NULL
and	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
inhibited	NULL
by	NULL
the	NULL
minor	NULL
groove	NULL
binding	NULL
polyamides	NULL
.	NULL

Ets-1	NULL
predominantly	NULL
contacts	NULL
the	NULL
major	NULL
groove	NULL
in	NULL
the	NULL
center	NULL
of	NULL
its	NULL
binding	NULL
site	NULL
,	NULL
with	NULL
additional	NULL
flanking	NULL
contacts	NULL
that	NULL
are	NULL
possibly	NULL
in	NULL
the	NULL
minor	NULL
groove	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

The	NULL
DNA-recognition	NULL
sites	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
are	NULL
not	NULL
optimal	NULL
polyamide	NULL
target	NULL
sequences	NULL
because	NULL
they	NULL
are	NULL
found	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
many	NULL
cellular	NULL
protein-coding	NULL
genes	NULL
.	NULL

However	NULL
,	NULL
the	NULL
sequences	NULL
immediately	NULL
flanking	NULL
these	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
often	NULL
are	NULL
conserved	NULL
for	NULL
a	NULL
particular	NULL
gene	NULL
,	NULL
providing	NULL
an	NULL
address	NULL
for	NULL
gene-specific	NULL
targeting	NULL
.	NULL

This	NULL
study	NULL
demonstrates	NULL
how	NULL
gene-specific	NULL
polyamide	NULL
inhibition	NULL
can	NULL
be	NULL
achieved	NULL
by	NULL
targeting	NULL
sequences	NULL
that	NULL
are	NULL
located	NULL
adjacent	NULL
to	NULL
,	NULL
but	NULL
do	NULL
not	NULL
coincide	NULL
with	NULL
,	NULL
binding	NULL
sites	NULL
for	NULL
transcriptional	NULL
regulators	NULL
and	NULL
how	NULL
strategic	NULL
targeting	NULL
of	NULL
multiple	NULL
transcription	NULL
factors	NULL
can	NULL
result	NULL
in	NULL
effective	NULL
inhibition	NULL
of	NULL
a	NULL
pol	NULL
II	NULL
promoter	NULL
and	NULL
viral	NULL
replication	NULL
in	NULL
human	NULL
cells	NULL
.	NULL

METHODS	NULL
Polyamides	NULL
.	NULL

Polyamides	NULL
1-4	NULL
were	NULL
synthesized	NULL
by	NULL
solid	NULL
phase	NULL
methods	NULL
as	NULL
described	NULL
(	NULL
13	NULL
)	NULL
.	NULL

DNA-Binding	NULL
Assays	NULL
.	NULL

Recombinant	NULL
human	NULL
TBP	NULL
(	NULL
Promega	NULL
)	NULL
was	NULL
used	NULL
at	NULL
0.14	NULL
nM	NULL
in	NULL
gel	NULL
mobility	NULL
shift	NULL
experiments	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
poly	NULL
dG-poly	NULL
dC	NULL
per	NULL
10	NULL
pl	NULL
of	NULL
reaction	NULL
as	NULL
recommended	NULL
.	NULL

A	NULL
50-bp	NULL
kinase-labeled	NULL
oligonucleotide	NULL
,	NULL
corresponding	NULL
to	NULL
positions	NULL
-46	NULL
to	NULL
+4	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
(	NULL
9	NULL
)	NULL
,	NULL
was	NULL
used	NULL
at	NULL
1.5	NULL
nM	NULL
final	NULL
concentration	NULL
.	NULL

The	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
TATA	NULL
region	NULL
oligonucleotide	NULL
had	NULL
the	NULL
top-strand	NULL
sequence	NULL
5-GATCGGGGGCTATAAAAGGGGGTGGG-3	NULL
'	NULL
and	NULL
the	NULL
complementary	NULL
bottom-strand	NULL
sequence	NULL
.	NULL

Six	NULL
percent	NULL
nonde-naturing	NULL
polyacrylamide	NULL
gels	NULL
containing	NULL
44	NULL
mM	NULL
Tris-borate	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
4	NULL
mM	NULL
MgCl	NULL
»	NULL
,	NULL
and	NULL
0.02	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
Nonidet	NULL
P-40	NULL
were	NULL
used	NULL
.	NULL

Recombinant	NULL
LEF-1	NULL
protein	NULL
containing	NULL
the	NULL
86-aa	NULL
DNA-binding	NULL
domain	NULL
was	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
J	NULL
.	NULL

Love	NULL
(	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
14	NULL
)	NULL
.	NULL

DNA	NULL
binding	NULL
reactions	NULL
,	NULL
containing	NULL
8	NULL
nM	NULL
LEF-1	NULL
,	NULL
were	NULL
performed	NULL
in	NULL
10	NULL
mM	NULL
Hepes-OH	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
MgCl	NULL
»	NULL
,	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
,	NULL
250	NULL
ng	NULL
of	NULL
poly	NULL
dG-poly	NULL
dC	NULL
,	NULL
and	NULL
50	NULL
pmol	NULL
of	NULL
a	NULL
singly	NULL
end-labeled	NULL
400-bp	NULL
restriction	NULL
fragment	NULL
isolated	NULL
from	NULL
pHIV	NULL
long	NULL
terminal	NULL
repeat-chloramphenicol	NULL
acetyl	NULL
transferase	NULL
plasmid	NULL
DNA	NULL
(	NULL
obtained	NULL
from	NULL
K.	NULL
A.	NULL
Jones	NULL
,	NULL
Salk	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
15	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
reactions	NULL
were	NULL
as	NULL
described	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Recombinant	NULL
Ets-1	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
AN331	NULL
)	NULL
kindly	NULL
was	NULL
provided	NULL
by	NULL
B.	NULL
Graves	NULL
,	NULL
(	NULL
University	NULL
of	NULL
Utah	NULL
)	NULL
and	NULL
was	NULL
used	NULL
at	NULL
12	NULL
nM	NULL
in	NULL
gel	NULL
Abbreviations	NULL
:	NULL
Py	NULL
,	NULL
pyrrole	NULL
;	NULL
Im	NULL
,	NULL
imidazole	NULL
;	NULL
pol	NULL
II	NULL
,	NULL
RNA	NULL
polymerase	NULL
II	NULL
;	NULL
LEF-1	NULL
,	NULL
lymphoid-enhancer-binding	NULL
factor	NULL
1	NULL
;	NULL
TBP	NULL
,	NULL
TATA-box	NULL
binding	NULL
protein	NULL
;	NULL
HIV-1	NULL
,	NULL
HIV	NULL
type	NULL
1	NULL
;	NULL
PBMC	NULL
,	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
;	NULL
CMV	NULL
,	NULL
cytomegalovirus	NULL
.	NULL

A	NULL
Commentary	NULL
on	NULL
this	NULL
article	NULL
begins	NULL
on	NULL
page	NULL
12739	NULL
.	NULL

$	NULL
To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

email	NULL
:	NULL
joelg	NULL
@	NULL
scripps	NULL
.	NULL

edu	NULL
and	NULL
dervan	NULL
@	NULL
cco.caltech.edu	NULL
.	NULL

Biochemistry	NULL
:	NULL
Dickinson	NULL
et	NULL
al	NULL
.	NULL

mobility	NULL
shift	NULL
experiments	NULL
(	NULL
16	NULL
)	NULL
along	NULL
with	NULL
50	NULL
pmol	NULL
of	NULL
a	NULL
43-bp	NULL
HIV-1	NULL
oligonucleotide	NULL
(	NULL
positions	NULL
-160	NULL
to	NULL
-117	NULL
)	NULL
.	NULL

In	NULL
Vitro	NULL
Transcription	NULL
.	NULL

Transcription	NULL
was	NULL
monitored	NULL
with	NULL
a	NULL
nuclear	NULL
extract	NULL
from	NULL
HeLa	NULL
cells	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
human	NULL
lymphoid	NULL
cell	NULL
line	NULL
H9	NULL
(	NULL
ATCC	NULL
HTB	NULL
176	NULL
)	NULL
was	NULL
grown	NULL
as	NULL
described	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
hypotonic	NULL
lysis	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Run-off	NULL
RNA	NULL
transcripts	NULL
of	NULL
~300	NULL
bases	NULL
[	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
major	NULL
immediate	NULL
early	NULL
promoter	NULL
linked	NULL
to	NULL
a	NULL
guanine-less	NULL
cassette	NULL
,	NULL
pE1B-GL	NULL
(	NULL
19	NULL
)	NULL
]	NULL
and	NULL
~500	NULL
bases	NULL
(	NULL
pHIV	NULL
long	NULL
terminal	NULL
repeat-chloramphenicol	NULL
aceytyl	NULL
transferase	NULL
)	NULL
were	NULL
obtained	NULL
with	NULL
EcoRI-digested	NULL
plasmid	NULL
DNA	NULL
(	NULL
100	NULL
ng	NULL
per	NULL
25	NULL
ul	NULL
reaction	NULL
)	NULL
.	NULL

Polyamide-DNA	NULL
complexes	NULL
were	NULL
allowed	NULL
to	NULL
form	NULL
at	NULL
ambient	NULL
temperature	NULL
for	NULL
15-30	NULL
min	NULL
before	NULL
addition	NULL
of	NULL
extracts	NULL
.	NULL

Transcription	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
H9	NULL
cell	NULL
extract	NULL
was	NULL
immunodepleted	NULL
with	NULL
antibody	NULL
to	NULL
LEF-1	NULL
(	NULL
provided	NULL
by	NULL
K.	NULL
Jones	NULL
)	NULL
prebound	NULL
to	NULL
protein	NULL
A	NULL
Sepharose	NULL
beads	NULL
as	NULL
described	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
efficiency	NULL
of	NULL
immunodepletion	NULL
was	NULL
determined	NULL
by	NULL
subjecting	NULL
depleted	NULL
and	NULL
mock-depleted	NULL
extracts	NULL
to	NULL
SDS/PAGE	NULL
and	NULL
Western	NULL
blotting	NULL
and	NULL
was	NULL
found	NULL
to	NULL
be	NULL
>	NULL
95	NULL
%	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
LEF-1	NULL
antibody	NULL
(	NULL
diluted	NULL
1:2500	NULL
)	NULL
and	NULL
was	NULL
detected	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Virus	NULL
Replication	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
were	NULL
separated	NULL
from	NULL
whole	NULL
blood	NULL
collected	NULL
from	NULL
normal	NULL
adult	NULL
volunteers	NULL
by	NULL
density	NULL
gradient	NULL
centrifugation	NULL
as	NULL
described	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Donors	NULL
were	NULL
provided	NULL
by	NULL
the	NULL
General	NULL
Clinical	NULL
Research	NULL
Center	NULL
of	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
which	NULL
is	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
MO1	NULL
RRO0833	NULL
.	NULL

PBMC	NULL
were	NULL
activated	NULL
with	NULL
2	NULL
ug/ml	NULL
phytohemag-glutinin	NULL
and	NULL
20	NULL
units/ml	NULL
of	NULL
interleukin	NULL
2	NULL
for	NULL
2-3	NULL
days	NULL
before	NULL
HIV-1	NULL
infection	NULL
.	NULL

Each	NULL
culture	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
PBMC	NULL
was	NULL
infected	NULL
with	NULL
10°	NULL
tissue	NULL
culture	NULL
infectious	NULL
doses	NULL
of	NULL
HIV-1	NULL
for	NULL
24	NULL
hours	NULL
;	NULL
free	NULL
virus	NULL
was	NULL
removed	NULL
by	NULL
washing	NULL
the	NULL
cells	NULL
in	NULL
medium	NULL
,	NULL
and	NULL
polyamides	NULL
were	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
.	NULL

Virus	NULL
replication	NULL
in	NULL
culture	NULL
was	NULL
measured	NULL
by	NULL
HIV-1	NULL
p24	NULL
viral	NULL
capsid	NULL
antigen	NULL
ELISA	NULL
(	NULL
Dupont	NULL
)	NULL
.	NULL

Assays	NULL
of	NULL
HIV-1	NULL
replication	NULL
were	NULL
performed	NULL
five	NULL
times	NULL
with	NULL
five	NULL
human	NULL
PBMC	NULL
donors	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Polyamide	NULL
Design	NULL
.	NULL

The	NULL
sequence	NULL
5'-	NULL
(	NULL
¥	NULL
,	NULL
T	NULL
)	NULL
GC	NULL
(	NULL
A	NULL
,	NULL
T	NULL
)	NULL
GC	NULL
(	NULL
A	NULL
,	NULL
T	NULL
)	NULL
-3	NULL
'	NULL
is	NULL
present	NULL
on	NULL
both	NULL
sides	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
and	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
Ets-1	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
sequence	NULL
5'-AGTACT-3	NULL
'	NULL
is	NULL
found	NULL
between	NULL
the	NULL
recognition	NULL
sites	NULL
for	NULL
Ets-1	NULL
and	NULL
LEF-1	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

These	NULL
sequences	NULL
are	NULL
conserved	NULL
for	NULL
most	NULL
reported	NULL
strains	NULL
of	NULL
HIV-1	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
propensity	NULL
for	NULL
mutation	NULL
at	NULL
these	NULL
sites	NULL
is	NULL
unknown	NULL
,	NULL
allowed	NULL
sequence	NULL
changes	NULL
in	NULL
the	NULL
promoter	NULL
could	NULL
be	NULL
targeted	NULL
with	NULL
new	NULL
polyamides	NULL
designed	NULL
by	NULL
the	NULL
pairing	NULL
rules	NULL
.	NULL

According	NULL
to	NULL
these	NULL
rules	NULL
,	NULL
5'-	NULL
(	NULL
A	NULL
,	NULL
T	NULL
)	NULL
GC	NULL
(	NULL
A	NULL
,	NULL
T	NULL
)	NULL
GC	NULL
(	NULL
A	NULL
,	NULL
T	NULL
)	NULL
-3	NULL
'	NULL
sequences	NULL
may	NULL
be	NULL
targeted	NULL
by	NULL
hairpin	NULL
polyamide	NULL
1	NULL
having	NULL
sequence	NULL
composition	NULL
ImPy-B-ImPy-y-ImPy-B-ImPy-B-Dp	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
B/B	NULL
pairing	NULL
recognizes	NULL
both	NULL
AT	NULL
and	NULL
T-A	NULL
bp	NULL
(	NULL
24	NULL
)	NULL
,	NULL
polyamide	NULL
1	NULL
is	NULL
expected	NULL
to	NULL
bind	NULL
to	NULL
all	NULL
three	NULL
sites	NULL
.	NULL

Quantitative	NULL
footprint	NULL
titration	NULL
experiments	NULL
revealed	NULL
that	NULL
polyamide	NULL
1	NULL
binds	NULL
to	NULL
each	NULL
of	NULL
these	NULL
sites	NULL
with	NULL
an	NULL
equilibrium	NULL
dissociation	NULL
constant	NULL
(	NULL
Ky	NULL
)	NULL
of	NULL
0.05	NULL
nM	NULL
.	NULL

A	NULL
mismatch	NULL
control	NULL
polyamide	NULL
ImIm-B-ImIm-y-PyPy-B-PyPy-B-Dp	NULL
(	NULL
2	NULL
)	NULL
,	NULL
which	NULL
differs	NULL
only	NULL
in	NULL
the	NULL
placement	NULL
of	NULL
the	NULL
Im	NULL
and	NULL
Py	NULL
amino	NULL
acids	NULL
,	NULL
binds	NULL
the	NULL
5-	NULL
(	NULL
A	NULL
,	NULL
T	NULL
)	NULL
GC	NULL
(	NULL
A	NULL
,	NULL
T	NULL
)	NULL
GC	NULL
(	NULL
A	NULL
,	NULL
T	NULL
)	NULL
-3	NULL
'	NULL
sites	NULL
with	NULL
100-fold	NULL
reduced	NULL
affinity	NULL
relative	NULL
to	NULL
polyamide	NULL
1	NULL
.	NULL

According	NULL
to	NULL
the	NULL
pairing	NULL
rules	NULL
,	NULL
the	NULL
sequence	NULL
5'-AGTACT-3	NULL
'	NULL
,	NULL
between	NULL
the	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
binding	NULL
sites	NULL
,	NULL
will	NULL
be	NULL
bound	NULL
by	NULL
polyamide	NULL
3	NULL
of	NULL
sequence	NULL
composition	NULL
ImPyPyPy-y-ImPyPyPy-B-Dp	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Quantitative	NULL
footprint	NULL
titration	NULL
experiments	NULL
revealed	NULL
that	NULL
polyamide	NULL
3	NULL
binds	NULL
this	NULL
site	NULL
with	NULL
K4	NULL
=	NULL
0.06	NULL
nM	NULL
.	NULL

Mismatch	NULL
polyamide	NULL
4	NULL
binds	NULL
this	NULL
sequence	NULL
with	NULL
>	NULL
100-fold	NULL
reduced	NULL
affinity	NULL
.	NULL

Inhibition	NULL
of	NULL
TBP	NULL
Binding	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
TBP	NULL
subunit	NULL
of	NULL
TFIID	NULL
in	NULL
the	NULL
minor	NULL
groove	NULL
nucleates	NULL
assembly	NULL
of	NULL
the	NULL
pol	NULL
II	NULL
transcription	NULL
machinery	NULL
for	NULL
TATA-containing	NULL
genes	NULL
(	NULL
25-27	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
-	NULL
12891	NULL
55-G	NULL
A	NULL
G	NULL
C	NULL
TIG	NULL
C	NULL
A	NULL
T	NULL
C	NULL
C	NULL
G	NULL
G	NULL
ALG	NULL
T	NULL
A	NULL
C	NULL
T	NULL
A\C	NULL
A	NULL
A	NULL
A	NULL
G	NULL
A	NULL
C	NULL
#	NULL
0	NULL
]	NULL
©	NULL
P	NULL
3r-cC	NULL
m	NULL
CG	NULL
al€é	NULL
@	NULL
r	NULL
a	NULL
cc	NULL
c	NULL
c	NULL
TJC	NULL
A	NULL
T	NULL
GA	NULL
TG	NULL
T	NULL
TT	NULL
C	NULL
T	NULL
ClaA-5	NULL
'	NULL
ETS-1	NULL
3	NULL
LEF-1	NULL
ETSA	NULL
LEFA	NULL
~~~	NULL
NFB	NULL
Sp1	NULL
CJ	NULL
5'-A	NULL
G	NULL
A	NULL
T	NULL
G	NULL
C	NULL
T	NULL
G	NULL
C	NULL
AT	NULL
A	NULL
T	NULL
A	NULL
AlG	NULL
C	NULL
A	NULL
G	NULL
CT	NULL
G	NULL
Co	NULL
T-3	NULL
'	NULL
#	NULL
3'-T	NULL
C	NULL
T	NULL
A	NULL
C	NULL
G	NULL
A	NULL
C	NULL
G	NULL
TIA	NULL
T	NULL
A	NULL
T	NULL
TJC	NULL
G	NULL
T	NULL
C	NULL
G	NULL
A	NULL
C	NULL
G	NULL
A-5	NULL
``	NULL
1	NULL
TBP	NULL
1	NULL
B	NULL
1	NULL
9	NULL
po	NULL
9	NULL
MM	NULL
N	NULL
1	NULL
109	NULL
Jigﬂu	NULL
a	NULL
Match	NULL
1	NULL
(	NULL
yn	NULL
8	NULL
``	NULL
~	NULL
``	NULL
u	NULL
nee®	NULL
G	NULL
C	NULL
T	NULL
G	NULL
C	NULL
a-3	NULL
'	NULL
{	NULL
13k	NULL
*	NULL
o	NULL
ur	NULL
6	NULL
H	NULL
“	NULL
Wu	NULL
3	NULL
o	NULL
1	NULL
b	NULL
u	NULL
hat	NULL
o5	NULL
)	NULL
m	NULL
m	NULL
”	NULL
(	NULL
£150	NULL
¥	NULL
n	NULL
BKdAgoZANTGTS	NULL
poi	NULL
AG	NULL
C	NULL
=	NULL
0.05	NULL
n	NULL
7	NULL
N	NULL
1	NULL
0	NULL
0	NULL
e	NULL
7	NULL
1	NULL
g	NULL
ﬂ	NULL
,	NULL
n	NULL
.	NULL

2	NULL
“	NULL
kid	NULL
F	NULL
N	NULL
``	NULL
,	NULL
,	NULL
Mismatch	NULL
a	NULL
N	NULL
N	NULL
so-r	NULL
cleir	NULL
irene	NULL
milvie	NULL
2500	NULL
C	NULL
og	NULL
oof	NULL
w	NULL
NO	NULL
H	NULL
N	NULL
N	NULL
§	NULL
3	NULL
1	NULL
©	NULL
OOC	NULL
OO	NULL
“	NULL
(	NULL
Q—	NULL
{	NULL
WON	NULL
YoY	NULL
ic	NULL
-	NULL
&	NULL
C	NULL
[	NULL
8	NULL
]	NULL
A	NULL
+	NULL
H	NULL
H	NULL
H	NULL
Faanlga	NULL
N	NULL
0	NULL
|	NULL
Ky	NULL
=	NULL
5.0	NULL
nM	NULL
_L	NULL
M	NULL
3	NULL
e	NULL
MN	NULL
a	NULL
Match	NULL
G	NULL
T	NULL
A	NULL
C	NULL
T-3	NULL
'	NULL
Hm/lj	NULL
w	NULL
3°-T	NULL
C	NULL
A	NULL
T	NULL
G	NULL
A-5	NULL
!	NULL

o	NULL
H	NULL
B	NULL
1	NULL
=	NULL
No	NULL
N	NULL
o	NULL
!	NULL

Ky	NULL
=	NULL
0.06	NULL
nM	NULL
YO	NULL
BY	NULL
¢*	NULL
1	NULL
9	NULL
€	NULL
h	NULL
.	NULL

4	NULL
e	NULL
MN	NULL
a	NULL
Mismatch	NULL
1	NULL
OWN	NULL
a	NULL
``	NULL
p	NULL
``	NULL
5a	NULL
c	NULL
t	NULL
alCT-3	NULL
!	NULL

(	NULL
f	NULL
,	NULL
x	NULL
``	NULL
Co.	NULL
,	NULL
``	NULL
“	NULL
VG	NULL
i	NULL
No	NULL
H	NULL
NW	NULL
o	NULL
!	NULL

*	NULL
“	NULL
Yd	NULL
Y	NULL
y	NULL
C	NULL
A	NULL
T|	NULL
@	NULL
ja-5	NULL
!	NULL

—N\/\	NULL
,	NULL
NY\	NULL
,	NULL
zw/	NULL
[	NULL
N_S	NULL
§	NULL
Y	NULL
Ky	NULL
=	NULL
2.0	NULL
nM	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

Polyamide	NULL
and	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Schematic	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
and	NULL
promoter	NULL
(	NULL
nucleotide	NULL
positions	NULL
-199	NULL
to	NULL
+1	NULL
)	NULL
showing	NULL
binding	NULL
sites	NULL
for	NULL
polyamides	NULL
1	NULL
and	NULL
3	NULL
and	NULL
the	NULL
transcription	NULL
factors	NULL
upstream	NULL
stimulatory	NULL
factor	NULL
,	NULL
Ets-1	NULL
(	NULL
39	NULL
,	NULL
40	NULL
)	NULL
,	NULL
LEF-1	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
Sp1	NULL
,	NULL
and	NULL
TFIID	NULL
(	NULL
TBP	NULL
)	NULL
.	NULL

For	NULL
polyamide	NULL
binding	NULL
models	NULL
:	NULL
shaded	NULL
and	NULL
unshaded	NULL
circles	NULL
,	NULL
Im	NULL
and	NULL
Py	NULL
rings	NULL
,	NULL
respectively	NULL
;	NULL
curved	NULL
lines	NULL
,	NULL
y-aminobutyric	NULL
acid	NULL
(	NULL
y	NULL
)	NULL
;	NULL
diamonds	NULL
,	NULL
B-alanine	NULL
(	NULL
B	NULL
)	NULL
;	NULL
and	NULL
Dp	NULL
,	NULL
dimethylaminopropylamide	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Structures	NULL
of	NULL
polyamides	NULL
ImPy-y-ImPy-6-ImPy-8-Dp	NULL
(	NULL
1	NULL
)	NULL
,	NULL
ImIm-8-ImIm-y-PyPy-8-PyPy-6-Dp	NULL
(	NULL
2	NULL
)	NULL
,	NULL
ImPyPyPy-y.ImPyPyPy-B-Dp	NULL
(	NULL
3	NULL
)	NULL
,	NULL
and	NULL
ImPyPyPy-y-PyPyPyPy-B-Dp	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Binding	NULL
models	NULL
and	NULL
measured	NULL
dissociation	NULL
constants	NULL
are	NULL
shown	NULL
.	NULL

Mismatches	NULL
are	NULL
highlighted	NULL
.	NULL

TBP	NULL
binds	NULL
the	NULL
HIV-1	NULL
TATA	NULL
element	NULL
with	NULL
a	NULL
Kq	NULL
of	NULL
~1-3	NULL
nM	NULL
.	NULL

A	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
revealed	NULL
that	NULL
polyamide	NULL
1	NULL
inhibits	NULL
TBP	NULL
binding	NULL
to	NULL
a	NULL
double	NULL
stranded	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
HIV-1	NULL
TATA	NULL
box	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
3-5	NULL
)	NULL
whereas	NULL
no	NULL
inhibition	NULL
was	NULL
observed	NULL
for	NULL
control	NULL
polyamide	NULL
2	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
13-15	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
polyamide	NULL
1	NULL
does	NULL
not	NULL
inhibit	NULL
TBP	NULL
binding	NULL
to	NULL
the	NULL
TATA	NULL
box	NULL
region	NULL
of	NULL
the	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
(	NULL
5'-GGGGGCTATAAAAGGGGGT-3	NULL
'	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
mismatch	NULL
flanking	NULL
sequences	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
8-10	NULL
)	NULL
.	NULL

The	NULL
half-life	NULL
of	NULL
the	NULL
polyamide	NULL
1-DNA	NULL
complex	NULL
was	NULL
determined	NULL
by	NULL
competition	NULL
experiments	NULL
to	NULL
be	NULL
in	NULL
excess	NULL
of	NULL
2.5	NULL
hours	NULL
.	NULL

Inhibition	NULL
of	NULL
Ets-1	NULL
Binding	NULL
.	NULL

The	NULL
Ets-1	NULL
recognition	NULL
site	NULL
in	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
is	NULL
flanked	NULL
by	NULL
binding	NULL
sites	NULL
for	NULL
polyamides	NULL
1	NULL
and	NULL
3	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
isolated	NULL
Ets-1	NULL
DNA-binding	NULL
domain	NULL
,	NULL
AN331	NULL
(	NULL
amino	NULL
acids	NULL
331	NULL
to	NULL
416	NULL
)	NULL
(	NULL
16	NULL
)	NULL
bound	NULL
to	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
with	NULL
a	NULL
K4	NULL
of	NULL
~0.5	NULL
nM	NULL
.	NULL

When	NULL
polyamides	NULL
were	NULL
preincubated	NULL
with	NULL
the	NULL
labeled	NULL
,	NULL
double-stranded	NULL
HIV-1	NULL
oligonucleotide	NULL
before	NULL
adding	NULL
AN331	NULL
,	NULL
polyamide	NULL
3	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
Ets-1	NULL
DNA-binding	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
3-5	NULL
)	NULL
.	NULL

Polyamide	NULL
1	NULL
,	NULL
how	NULL
12892	NULL
-	NULL
Biochemistry	NULL
:	NULL
Dickinson	NULL
et	NULL
al	NULL
.	NULL

A	NULL
DNA	NULL
Probe	NULL
HIV	NULL
AdML	NULL
HIV	NULL
_	NULL
,	NULL
Polyamide	NULL
-	NULL
-_-	NULL
]	NULL
-	NULL
-	NULL
C	NULL
-	NULL
_	NULL
--	NULL
-4	NULL
]	NULL
TBP	NULL
-	NULL
+	NULL
4+	NULL
%	NULL
4	NULL
-	NULL
4	NULL
4	NULL
4	NULL
4	NULL
-	NULL
%	NULL
4	NULL
4	NULL
4	NULL
%	NULL
1	NULL
-	NULL
miriam	NULL
nun	NULL
...	NULL
m	NULL
»	NULL
-bap	NULL
F	NULL
F	NULL
102	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
&	NULL
g	NULL
g0	NULL
dn	NULL
92	NULL
93	NULL
ma	NULL
as	NULL
B	NULL
Polyamide	NULL
-	NULL
-	NULL
%	NULL
ANSB1	NULL
-	NULL
4	NULL
%	NULL
4	NULL
+	NULL
%	NULL
#	NULL
4	NULL
4	NULL
4	NULL
+	NULL
4	NULL
4	NULL
+	NULL
+	NULL
+	NULL
B	NULL
®	NULL
parannigptetied	NULL
_	NULL
F	NULL
Wo	NULL
me	NULL
c	NULL
mn	NULL
Ses	NULL
sem	NULL
102	NULL
s	NULL
4	NULL
£06	NULL
7	NULL
&	NULL
0g	NULL
10	NULL
th	NULL
12	NULL
ns	NULL
ad	NULL
C	NULL
Polyamide	NULL
-	NULL
LEF1	NULL
--	NULL
--	NULL
--	NULL
+4++++	NULL
+++	NULL
tcencg	NULL
``	NULL
u	NULL
``	NULL
=	NULL
P3~1	NULL
(	NULL
-_-_	NULL
'	NULL
I	NULL
~	NULL
se-e=	NULL
``	NULL
``	NULL
``	NULL
1+-HSS	NULL
P3-2	NULL
t	NULL
C	NULL
s®=8®	NULL
~L1	NULL
mm	NULL
ue	NULL
me	NULL
we	NULL
tn	NULL
Jt2	NULL
IIyIE	NULL
-ss=z=~~	NULL
%	NULL
_-	NULL
|L3	NULL
P34	NULL
[	NULL
~	NULL
sist	NULL
%	NULL
ri	NULL
v¥4	NULL
-h-	NULL
&	NULL
ket	NULL
.40448-8+	NULL
123	NULL
4	NULL
5	NULL
6	NULL
7	NULL
a	NULL
sa0m2n0n	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Inhibition	NULL
of	NULL
transcription	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
HIV-1	NULL
promoter	NULL
and	NULL
enhancer	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Gel	NULL
mobility	NULL
shift	NULL
assay	NULL
with	NULL
TBP	NULL
and	NULL
polyamides	NULL
1	NULL
and	NULL
2	NULL
.	NULL

Oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
HIV-1	NULL
TATA	NULL
box	NULL
(	NULL
lanes	NULL
1-5	NULL
and	NULL
11-15	NULL
)	NULL
or	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
TATA	NULL
box	NULL
(	NULL
lanes	NULL
6-10	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
no	NULL
polyamide	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
6	NULL
,	NULL
7	NULL
,	NULL
11	NULL
,	NULL
and	NULL
12	NULL
)	NULL
,	NULL
50	NULL
nM	NULL
polyamide	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
8	NULL
,	NULL
and	NULL
13	NULL
)	NULL
,	NULL
100	NULL
nM	NULL
polyamide	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
9	NULL
,	NULL
and	NULL
14	NULL
)	NULL
,	NULL
and	NULL
200	NULL
nM	NULL
polyamide	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
10	NULL
,	NULL
and	NULL
15	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
recombinant	NULL
human	NULL
TBP	NULL
,	NULL
as	NULL
indicated	NULL
(	NULL
+	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
free	NULL
probes	NULL
(	NULL
F	NULL
)	NULL
and	NULL
the	NULL
monomer	NULL
and	NULL
dimer	NULL
TBP-DNA	NULL
complexes	NULL
(	NULL
B	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Differential	NULL
effect	NULL
of	NULL
polyamide	NULL
1	NULL
and	NULL
3	NULL
on	NULL
Ets-1	NULL
DNA-binding	NULL
.	NULL

Polyamide	NULL
concentrations	NULL
were	NULL
100	NULL
nM	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
12	NULL
)	NULL
,	NULL
200	NULL
nM	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
13	NULL
)	NULL
,	NULL
and	NULL
400	NULL
nM	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
8	NULL
,	NULL
11	NULL
,	NULL
14	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
DNase	NULL
I	NULL
footprint	NULL
experiment	NULL
with	NULL
LEF-1	NULL
{	NULL
Janes	NULL
7	NULL
to	NULL
14	NULL
)	NULL
and	NULL
polyamide	NULL
3	NULL
used	NULL
at	NULL
the	NULL
following	NULL
concentrations	NULL
:	NULL
no	NULL
polyamide	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
7	NULL
)	NULL
,	NULL
10	NULL
pM	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
8	NULL
)	NULL
,	NULL
30	NULL
pM	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
0.1	NULL
nM	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
10	NULL
)	NULL
,	NULL
0.3	NULL
nM	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
,	NULL
1	NULL
nM	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
12	NULL
)	NULL
,	NULL
3	NULL
nM	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
13	NULL
)	NULL
,	NULL
and	NULL
10	NULL
nM	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
14	NULL
)	NULL
.	NULL

Polyamides	NULL
and	NULL
DNA	NULL
were	NULL
incubated	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

ever	NULL
,	NULL
prevented	NULL
the	NULL
Ets-1/DNA	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
9-11	NULL
)	NULL
.	NULL

The	NULL
two	NULL
mismatch	NULL
polyamides	NULL
2	NULL
and	NULL
4	NULL
did	NULL
not	NULL
prevent	NULL
complex	NULL
formation	NULL
(	NULL
lanes	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
6-8	NULL
and	NULL
12-14	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
revealed	NULL
that	NULL
polyamide	NULL
1	NULL
prevents	NULL
Ets-1	NULL
DNA-binding	NULL
whereas	NULL
polyamide	NULL
3	NULL
cooccupies	NULL
the	NULL
DNA	NULL
with	NULL
Ets-1	NULL
.	NULL

Polyamide	NULL
1	NULL
likely	NULL
inhibits	NULL
Ets-1	NULL
binding	NULL
by	NULL
steric	NULL
interaction	NULL
with	NULL
protein	NULL
contacts	NULL
in	NULL
the	NULL
minor	NULL
groove	NULL
whereas	NULL
polyamide	NULL
3	NULL
,	NULL
which	NULL
does	NULL
not	NULL
inhibit	NULL
Ets-1	NULL
binding	NULL
,	NULL
must	NULL
occupy	NULL
the	NULL
minor	NULL
groove	NULL
beyond	NULL
the	NULL
Ets-1	NULL
contacts	NULL
.	NULL

Inhibition	NULL
of	NULL
LEF-1	NULL
Binding	NULL
.	NULL

LEF-1	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
high	NULL
mobility	NULL
group	NULL
family	NULL
of	NULL
minor-groove	NULL
binding	NULL
proteins	NULL
(	NULL
14	NULL
)	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
HIV-1	NULL
transcription	NULL
and	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
replication	NULL
in	NULL
lymphoid	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Three	NULL
sites	NULL
on	NULL
the	NULL
HIV-1	NULL
promoter/enhancer	NULL
restriction	NULL
fragment	NULL
are	NULL
bound	NULL
by	NULL
the	NULL
86-aa	NULL
LEF-1	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
sites	NULL
L1	NULL
,	NULL
L2	NULL
,	NULL
and	NULL
L3	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
,	NULL
with	NULL
Kq	NULL
=	NULL
1.4	NULL
,	NULL
5.8	NULL
,	NULL
and	NULL
4.9	NULL
nM	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
LEF-1	NULL
footprint	NULL
at	NULL
site	NULL
L1	NULL
,	NULL
characterized	NULL
by	NULL
a	NULL
marked	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
site	NULL
,	NULL
changes	NULL
to	NULL
the	NULL
polyamide	NULL
footprint	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
match	NULL
polyamide	NULL
3	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
8-14	NULL
)	NULL
.	NULL

LEF-1	NULL
binding	NULL
is	NULL
inhibited	NULL
50	NULL
%	NULL
at	NULL
a	NULL
polyamide	NULL
3	NULL
concentration	NULL
of	NULL
~60	NULL
pM	NULL
.	NULL

Thus	NULL
,	NULL
polyamide	NULL
3	NULL
,	NULL
located	NULL
in	NULL
the	NULL
minor	NULL
groove	NULL
immediately	NULL
adjacent	NULL
to	NULL
site	NULL
L1	NULL
,	NULL
inhibits	NULL
LEF-1	NULL
binding	NULL
to	NULL
this	NULL
site	NULL
.	NULL

Polyamide	NULL
3	NULL
inhibits	NULL
LEF-1	NULL
binding	NULL
to	NULL
the	NULL
sites	NULL
L2	NULL
and	NULL
L3	NULL
at	NULL
markedly	NULL
higher	NULL
polyamide	NULL
concentrations	NULL
(	NULL
3	NULL
nM	NULL
and	NULL
above	NULL
;	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
13-14	NULL
)	NULL
because	NULL
there	NULL
are	NULL
no	NULL
high	NULL
affinity	NULL
polyamide	NULL
recognition	NULL
sites	NULL
adjacent	NULL
to	NULL
sites	NULL
L2	NULL
and	NULL
L3	NULL
.	NULL

Inhibition	NULL
was	NULL
observed	NULL
either	NULL
by	NULL
adding	NULL
the	NULL
polyamide	NULL
to	NULL
the	NULL
DNA	NULL
before	NULL
LEF-1	NULL
or	NULL
after	NULL
preincubation	NULL
of	NULL
the	NULL
DNA	NULL
with	NULL
LEF-1	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
relative	NULL
dissociation	NULL
constants	NULL
for	NULL
the	NULL
two	NULL
binding	NULL
reactions	NULL
.	NULL

Mismatch	NULL
polyamide	NULL
4	NULL
failed	NULL
to	NULL
inhibit	NULL
LEF-1	NULL
binding	NULL
.	NULL

Inhibition	NULL
of	NULL
Transcription	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
polyamides	NULL
1	NULL
and	NULL
2	NULL
on	NULL
HIV-1	NULL
transcription	NULL
were	NULL
tested	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
with	NULL
a	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL

Polyamide	NULL
1	NULL
inhibited	NULL
basal	NULL
transcription	NULL
from	NULL
the	NULL
HIV-1	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
lanes	NULL
2-4	NULL
)	NULL
but	NULL
not	NULL
from	NULL
the	NULL
CMV	NULL
major	NULL
immediate	NULL
early	NULL
promoter	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
mismatched	NULL
TATA-flanking	NULL
sequence	NULL
(	NULL
5'-GAGGTCTATATAAGCAGA-3	NULL
'	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
lanes	NULL
6-8	NULL
)	NULL
.	NULL

The	NULL
mismatch	NULL
polyamide	NULL
2	NULL
did	NULL
not	NULL
inhibit	NULL
transcription	NULL
from	NULL
either	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
lanes	NULL
10-12	NULL
and	NULL
14-16	NULL
)	NULL
.	NULL

We	NULL
performed	NULL
titrations	NULL
of	NULL
polyamide	NULL
1	NULL
over	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
concentrations	NULL
(	NULL
1	NULL
to	NULL
200	NULL
nM	NULL
)	NULL
with	NULL
both	NULL
of	NULL
the	NULL
HIV-1	NULL
and	NULL
CMV	NULL
templates	NULL
in	NULL
the	NULL
same	NULL
reaction	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
we	NULL
observed	NULL
50	NULL
%	NULL
inhibition	NULL
of	NULL
HIV-1	NULL
transcription	NULL
at	NULL
60	NULL
nM	NULL
polyamide	NULL
1	NULL
,	NULL
which	NULL
corresponds	NULL
to	NULL
a	NULL
6-	NULL
to	NULL
10-fold	NULL
excess	NULL
of	NULL
polyamide	NULL
over	NULL
binding	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
closed	NULL
triangles	NULL
)	NULL
.	NULL

No	NULL
significant	NULL
inhibition	NULL
of	NULL
CMV	NULL
transcription	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
open	NULL
circles	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
effects	NULL
of	NULL
polyamides	NULL
3	NULL
and	NULL
4	NULL
on	NULL
LEF-1-activated	NULL
HIV-1	NULL
transcription	NULL
,	NULL
we	NULL
supplemented	NULL
the	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
with	NULL
a	NULL
human	NULL
lymphoid	NULL
H9	NULL
cell	NULL
extract	NULL
,	NULL
which	NULL
contains	NULL
high	NULL
levels	NULL
of	NULL
LEF-1	NULL
protein	NULL
(	NULL
as	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
)	NULL
.	NULL

The	NULL
mixture	NULL
of	NULL
H9	NULL
and	NULL
HeLa	NULL
cell	NULL
extracts	NULL
stimulated	NULL
HIV-1	NULL
transcription	NULL
2.5-	NULL
to	NULL
3-fold	NULL
over	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
observed	NULL
with	NULL
the	NULL
HeLa	NULL
extract	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Immunodepletion	NULL
of	NULL
LEF-1	NULL
protein	NULL
from	NULL
the	NULL
H9	NULL
extract	NULL
abolished	NULL
this	NULL
activated	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Polyamide	NULL
3	NULL
inhibited	NULL
HIV-1	NULL
transcription	NULL
in	NULL
this	NULL
system	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
lanes	NULL
2-5	NULL
)	NULL
with	NULL
a	NULL
50	NULL
%	NULL
reduction	NULL
of	NULL
transcription	NULL
observed	NULL
at	NULL
10-30	NULL
nM	NULL
polyamide	NULL
.	NULL

Polyamide	NULL
3	NULL
failed	NULL
to	NULL
inhibit	NULL
HIV-1	NULL
transcription	NULL
in	NULL
the	NULL
LEF-1-depleted	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
lanes	NULL
7-10	NULL
)	NULL
.	NULL

We	NULL
also	NULL
monitored	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
CMV	NULL
major	NULL
immediate	NULL
early	NULL
promoter	NULL
in	NULL
both	NULL
the	NULL
mock-depleted	NULL
and	NULL
LEF-1-depleted	NULL
H9	NULL
cell	NULL
extract	NULL
,	NULL
with	NULL
the	NULL
result	NULL
that	NULL
LEF-1	NULL
depletion	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
CMV	NULL
transcription	NULL
.	NULL

As	NULL
additional	NULL
controls	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
mismatch	NULL
polyamide	NULL
4	NULL
on	NULL
HIV-1	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
and	NULL
polyamides	NULL
3	NULL
and	NULL
4	NULL
on	NULL
CMV	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
lanes	NULL
6-10	NULL
)	NULL
.	NULL

No	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
either	NULL
polyamide	NULL
3	NULL
or	NULL
4	NULL
are	NULL
present	NULL
in	NULL
the	NULL
CMV	NULL
major	NULL
immediate	NULL
early	NULL
promoter	NULL
sequence	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
polyamide	NULL
3	NULL
fails	NULL
to	NULL
inhibit	NULL
CMV	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
lanes	NULL
7-8	NULL
)	NULL
,	NULL
and	NULL
polyamide	NULL
4	NULL
fails	NULL
to	NULL
inhibit	NULL
either	NULL
HIV-1	NULL
or	NULL
CMV	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
lanes	NULL
4-5	NULL
and	NULL
9-10	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
polyamide	NULL
3	NULL
does	NULL
not	NULL
inhibit	NULL
basal	NULL
transcription	NULL
,	NULL
although	NULL
binding	NULL
sites	NULL
for	NULL
this	NULL
polyamide	NULL
are	NULL
present	NULL
at	NULL
the	NULL
start	NULL
site	NULL
for	NULL
transcription	NULL
and	NULL
within	NULL
the	NULL
HIV-1	NULL
RNA	NULL
coding	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
pol	NULL
II	NULL
can	NULL
transcribe	NULL
DNA	NULL
with	NULL
a	NULL
polyamide	NULL
bound	NULL
in	NULL
the	NULL
minor	NULL
groove	NULL
and	NULL
that	NULL
polyamides	NULL
are	NULL
only	NULL
inhibitory	NULL
to	NULL
transcription	NULL
when	NULL
these	NULL
compounds	NULL
interfere	NULL
with	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
a	NULL
required	NULL
transcription	NULL
factor	NULL
.	NULL

Inhibition	NULL
of	NULL
Virus	NULL
Replication	NULL
.	NULL

Because	NULL
there	NULL
are	NULL
multiple	NULL
spliced	NULL
and	NULL
unspliced	NULL
species	NULL
of	NULL
HIV-1	NULL
RNA	NULL
with	NULL
different	NULL
Biochemistry	NULL
:	NULL
Dickinson	NULL
et	NULL
al	NULL
.	NULL

_	NULL
,	NULL
CMV	NULL
_	NULL
,	NULL
,	NULL
;	NULL
CMV	NULL
-	NULL
_7	NULL
-	NULL
2-7	NULL
-	NULL
_	NULL
--	NULL
3	NULL
-	NULL
-_	NULL
--	NULL
3	NULL
®	NULL
an	NULL
am	NULL
win	NULL
wn	NULL
am	NULL
w	NULL
»	NULL
-HIV-1	NULL
=CMV	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
910	NULL
11	NULL
1213	NULL
14	NULL
15	NULL
16	NULL
%	NULL
Transcription	NULL
T	NULL
T	NULL
T	NULL
T	NULL
0	NULL
50	NULL
100	NULL
150	NULL
200	NULL
250	NULL
1	NULL
(	NULL
nM	NULL
)	NULL
p	NULL
H9	NULL
e	NULL
H9ALEF	NULL
m	NULL
ﬂ	NULL
-	NULL
ﬂ	NULL
Co	NULL
th	NULL
-	NULL
«	NULL
ae	NULL
mam	NULL
mas	NULL
ams	NULL
wae	NULL
-_|||\/-	NULL
|	NULL
10	NULL
20	NULL
3	NULL
40	NULL
5060	NULL
7	NULL
B8	NULL
9	NULL
10	NULL
D	NULL
HIV-1	NULL
CMV	NULL
aam	NULL
cas	NULL
«	NULL
ams	NULL
om	NULL
=HIV-1	NULL
=CMV	NULL
10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Polyamide	NULL
inhibition	NULL
of	NULL
HIV-1	NULL
transcription	NULL
in	NULL
vitro	NULL
.	NULL

(	NULL
4	NULL
)	NULL
DNA	NULL
templates	NULL
containing	NULL
the	NULL
HIV-1	NULL
promoter	NULL
(	NULL
lanes	NULL
1-4	NULL
and	NULL
9-12	NULL
)	NULL
and	NULL
the	NULL
CMV	NULL
major	NULL
immediate	NULL
early	NULL
promoter	NULL
(	NULL
lanes	NULL
5-8	NULL
and	NULL
13-16	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
following	NULL
concentrations	NULL
of	NULL
polyamide	NULL
1	NULL
or	NULL
2	NULL
(	NULL
as	NULL
indicated	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
:	NULL
no	NULL
polyamide	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
5	NULL
,	NULL
9	NULL
,	NULL
13	NULL
)	NULL
50	NULL
nM	NULL
polyamide	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
6	NULL
,	NULL
10	NULL
,	NULL
14	NULL
)	NULL
,	NULL
100	NULL
nM	NULL
{	NULL
Janes	NULL
3	NULL
,	NULL
7	NULL
,	NULL
11	NULL
,	NULL
15	NULL
)	NULL
,	NULL
and	NULL
200	NULL
nM	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
16	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Relative	NULL
levels	NULL
of	NULL
HIV-1	NULL
transcription	NULL
(	NULL
closed	NULL
triangles	NULL
)	NULL
compared	NULL
with	NULL
CMV	NULL
transcription	NULL
(	NULL
open	NULL
circles	NULL
)	NULL
are	NULL
plotted	NULL
as	NULL
a	NULL
function	NULL
of	NULL
polyamide	NULL
1	NULL
concentration	NULL
,	NULL
from	NULL
mixed	NULL
template	NULL
reactions	NULL
with	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Polyamide	NULL
3	NULL
inhibits	NULL
LEF-1-activated	NULL
transcription	NULL
.	NULL

Transcription	NULL
reactions	NULL
were	NULL
performed	NULL
with	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
supplemented	NULL
with	NULL
H9	NULL
whole	NULL
cell	NULL
extract	NULL
(	NULL
lanes	NULL
1-5	NULL
)	NULL
or	NULL
LEF-depleted	NULL
H9	NULL
extract	NULL
(	NULL
lanes	NULL
6-10	NULL
)	NULL
.	NULL

The	NULL
final	NULL
concentrations	NULL
of	NULL
polyamide	NULL
were	NULL
no	NULL
polyamide	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
,	NULL
10	NULL
nM	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
7	NULL
)	NULL
,	NULL
30	NULL
nM	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
8	NULL
)	NULL
,	NULL
100	NULL
nM	NULL
(	NULL
Janes	NULL
4	NULL
and	NULL
9	NULL
)	NULL
,	NULL
and	NULL
300	NULL
nM	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Transcription	NULL
with	NULL
mismatch	NULL
control	NULL
polyamide	NULL
4	NULL
and	NULL
control	NULL
CMV	NULL
template	NULL
.	NULL

Plasmid	NULL
DNA	NULL
was	NULL
incubated	NULL
with	NULL
polyamide	NULL
3	NULL
(	NULL
10	NULL
nM	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
7	NULL
;	NULL
100	NULL
nM	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
8	NULL
)	NULL
or	NULL
polyamide	NULL
4	NULL
(	NULL
10	NULL
nM	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
9	NULL
;	NULL
100	NULL
nM	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
)	NULL
.	NULL

turn-over	NULL
kinetics	NULL
(	NULL
29	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
HIV-1	NULL
transcription	NULL
indirectly	NULL
by	NULL
measuring	NULL
the	NULL
levels	NULL
and	NULL
kinetics	NULL
of	NULL
HIV-1	NULL
replication	NULL
in	NULL
human	NULL
PBMC	NULL
in	NULL
culture	NULL
.	NULL

PBMC	NULL
were	NULL
infected	NULL
with	NULL
the	NULL
T	NULL
cell-tropic	NULL
HIV-1	NULL
strain	NULL
WEAU1.6	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
or	NULL
with	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
-	NULL
12893	NULL
the	NULL
macrophage-tropic	NULL
strain	NULL
SF162	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Polyamides	NULL
were	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
,	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
HIV-1	NULL
p24	NULL
viral	NULL
capsid	NULL
protein	NULL
released	NULL
into	NULL
the	NULL
culture	NULL
media	NULL
(	NULL
primarily	NULL
as	NULL
virions	NULL
)	NULL
were	NULL
determined	NULL
on	NULL
subsequent	NULL
days	NULL
after	NULL
infection	NULL
by	NULL
using	NULL
a	NULL
standard	NULL
ELISA	NULL
assay	NULL
.	NULL

In	NULL
control	NULL
PBMC	NULL
cultures	NULL
with	NULL
no	NULL
added	NULL
polyamide	NULL
,	NULL
viral	NULL
replication	NULL
of	NULL
both	NULL
strains	NULL
resulted	NULL
in	NULL
increasing	NULL
p24	NULL
levels	NULL
between	NULL
4	NULL
and	NULL
10	NULL
days	NULL
of	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Polyamide	NULL
1	NULL
at	NULL
1	NULL
wM	NULL
concentration	NULL
caused	NULL
an	NULL
80	NULL
%	NULL
reduction	NULL
in	NULL
virus	NULL
whereas	NULL
polyamide	NULL
3	NULL
at	NULL
1	NULL
wM	NULL
concentration	NULL
caused	NULL
a	NULL
60	NULL
%	NULL
reduction	NULL
after	NULL
6	NULL
to	NULL
8	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
polyamides	NULL
1	NULL
+	NULL
3	NULL
inhibited	NULL
HIV-1	NULL
replication	NULL
at	NULL
10	NULL
nM	NULL
to	NULL
1	NULL
wM	NULL
concentration	NULL
,	NULL
but	NULL
the	NULL
closely	NULL
related	NULL
polyamides	NULL
2	NULL
+	NULL
4	NULL
did	NULL
not	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
polyamides	NULL
1	NULL
and	NULL
3	NULL
at	NULL
1	NULL
uM	NULL
each	NULL
acted	NULL
in	NULL
synergy	NULL
to	NULL
reduce	NULL
viral	NULL
p24	NULL
levels	NULL
to	NULL
below	NULL
the	NULL
threshold	NULL
of	NULL
detection	NULL
after	NULL
6-8	NULL
days	NULL
for	NULL
WEAU	NULL
(	NULL
<	NULL
10	NULL
pg/ml	NULL
;	NULL
>	NULL
99.9	NULL
%	NULL
inhibition	NULL
of	NULL
viral	NULL
replication	NULL
)	NULL
(	NULL
Figs	NULL
.	NULL

44	NULL
and	NULL
5C	NULL
)	NULL
and	NULL
were	NULL
as	NULL
effective	NULL
as	NULL
1	NULL
uM	NULL
azidothymidine	NULL
in	NULL
blocking	NULL
HIV-1	NULL
replication	NULL
.	NULL

The	NULL
macrophage-tropic	NULL
SF162	NULL
isolate	NULL
,	NULL
which	NULL
replicates	NULL
in	NULL
both	NULL
macrophages	NULL
and	NULL
CD4*	NULL
T-lymphocytes	NULL
,	NULL
was	NULL
not	NULL
inhibited	NULL
efficiently	NULL
by	NULL
either	NULL
polyamide	NULL
alone	NULL
,	NULL
but	NULL
the	NULL
combination	NULL
of	NULL
1	NULL
mM	NULL
each	NULL
polyamide	NULL
1	NULL
and	NULL
3	NULL
reduced	NULL
and	NULL
eventually	NULL
blocked	NULL
its	NULL
replication	NULL
after	NULL
10	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
mismatch	NULL
polyamides	NULL
2	NULL
and	NULL
4	NULL
,	NULL
which	NULL
differ	NULL
by	NULL
a	NULL
single	NULL
atomic	NULL
substitution	NULL
(	NULL
4	NULL
)	NULL
,	NULL
or	NULL
a	NULL
rearrangement	NULL
of	NULL
the	NULL
Im	NULL
and	NULL
Py	NULL
amino	NULL
acids	NULL
(	NULL
2	NULL
)	NULL
,	NULL
from	NULL
the	NULL
match	NULL
polyamides	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
level	NULL
of	NULL
virus	NULL
in	NULL
the	NULL
medium	NULL
,	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

The	NULL
inhibitory	NULL
effects	NULL
of	NULL
polyamides	NULL
was	NULL
not	NULL
caused	NULL
by	NULL
obvious	NULL
toxicity	NULL
.	NULL

No	NULL
significant	NULL
decrease	NULL
in	NULL
cell	NULL
viability	NULL
was	NULL
apparent	NULL
in	NULL
PBMC	NULL
cultures	NULL
treated	NULL
with	NULL
polyamides	NULL
1	NULL
and	NULL
3	NULL
for	NULL
10	NULL
days	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
90	NULL
%	NULL
mortality	NULL
observed	NULL
for	NULL
PBMC	NULL
cells	NULL
treated	NULL
with	NULL
1	NULL
wM	NULL
azidothymidine	NULL
for	NULL
the	NULL
same	NULL
period	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
slightly	NULL
higher	NULL
in	NULL
WEAU-infected	NULL
cultures	NULL
that	NULL
were	NULL
treated	NULL
with	NULL
polyamides	NULL
1	NULL
and	NULL
3	NULL
than	NULL
in	NULL
untreated	NULL
cultures	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
,	NULL
filled	NULL
circles	NULL
versus	NULL
open	NULL
circles	NULL
)	NULL
,	NULL
probably	NULL
because	NULL
the	NULL
cytopathic	NULL
effect	NULL
of	NULL
HIV-1	NULL
infection	NULL
was	NULL
reversed	NULL
completely	NULL
.	NULL

Cell	NULL
recovery	NULL
was	NULL
not	NULL
impacted	NULL
by	NULL
polyamide	NULL
treatment	NULL
but	NULL
was	NULL
reduced	NULL
by	NULL
azidothymidine	NULL
treat-ment	NULL
.	NULL

The	NULL
observed	NULL
polyamide	NULL
inhibition	NULL
of	NULL
virus	NULL
replication	NULL
is	NULL
likely	NULL
caused	NULL
by	NULL
interference	NULL
with	NULL
the	NULL
DNA-binding	NULL
activities	NULL
of	NULL
TBP	NULL
and	NULL
Ets-1	NULL
by	NULL
polyamide	NULL
1	NULL
and	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
LEF-1	NULL
by	NULL
polyamide	NULL
3	NULL
,	NULL
but	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
inhibition	NULL
of	NULL
A	NULL
B	NULL
2500	NULL
250	NULL
2000	NULL
-	NULL
200	NULL
{	NULL
1500	NULL
-|	NULL
L	NULL
150	NULL
HIV	NULL
p24	NULL
(	NULL
pg/m	NULL
!	NULL
)	NULL

1000	NULL
-|	NULL
|_	NULL
g	NULL
L	NULL
500	NULL
-	NULL
BY	NULL
1	NULL
|	NULL
so	NULL
none	NULL
0.01	NULL
0.1	NULL
1.0	NULL
pM	NULL
polyamide	NULL
none1.0	NULL
1.0	NULL
1.0	NULL
uM	NULL
polyamide	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

-	NULL
Polyamide	NULL
inhibition	NULL
of	NULL
HIV-1	NULL
replication	NULL
.	NULL

4	NULL
and	NULL
B	NULL
depict	NULL
two	NULL
independent	NULL
experiments	NULL
in	NULL
which	NULL
polyamides	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
were	NULL
added	NULL
to	NULL
cultures	NULL
of	NULL
PBMCs	NULL
,	NULL
obtained	NULL
from	NULL
two	NULL
separate	NULL
donors	NULL
,	NULL
infected	NULL
with	NULL
the	NULL
primary	NULL
HIV-1	NULL
isolate	NULL
WEAU	NULL
1.6	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
G.	NULL
Shaw	NULL
)	NULL
.	NULL

Replication	NULL
was	NULL
measured	NULL
6	NULL
or	NULL
8	NULL
days	NULL
after	NULL
infection	NULL
by	NULL
release	NULL
of	NULL
p24	NULL
capsid	NULL
antigen	NULL
into	NULL
the	NULL
medium	NULL
.	NULL

Assays	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
and	NULL
showed	NULL
<	NULL
5	NULL
%	NULL
variation	NULL
from	NULL
the	NULL
mean	NULL
.	NULL

In	NULL
B	NULL
,	NULL
polyamides	NULL
were	NULL
added	NULL
24	NULL
hours	NULL
before	NULL
virus	NULL
exposure	NULL
and	NULL
were	NULL
continuously	NULL
present	NULL
thereafter	NULL
.	NULL

12894	NULL
_	NULL
Biochemistry	NULL
:	NULL
Dickinson	NULL
et	NULL
al	NULL
.	NULL

A	NULL
B	NULL
25	NULL
100	NULL
A	NULL
SF	NULL
162	NULL
A	NULL
SF	NULL
1621	NULL
+3	NULL
ho	NULL
o	NULL
1.	NULL
pg/ml	NULL
p24	NULL
x	NULL
10°3	NULL
m	NULL
1	NULL
€	NULL
50	NULL
{	NULL
x	NULL
m	NULL
,	NULL
a	NULL
Mo	NULL
s	NULL
,	NULL
10-	NULL
3	NULL
A	NULL
5-	NULL
A	NULL
.	NULL

257	NULL
|	NULL
A	NULL
sr	NULL
ies	NULL
A	NULL
SF	NULL
162	NULL
t	NULL
+3	NULL
}	NULL
``	NULL
,	NULL
e	NULL
AZT	NULL
*	NULL
O	NULL
+7	NULL
T	NULL
T	NULL
&	NULL
0	NULL
~	NULL
62000028	NULL
.	NULL

10	NULL
C	NULL
days	NULL
after	NULL
infection	NULL
25	NULL
100	NULL
0	NULL
WEAU	NULL
@	NULL
WEAU	NULL
1	NULL
+3	NULL
207	NULL
&	NULL
75	NULL
3	NULL
]	NULL
x	NULL
€	NULL
157	NULL
2	NULL
3	NULL
€	NULL
50	NULL
2	NULL
§	NULL
104	NULL
s	NULL
*57	NULL
|	NULL
o	NULL
weal	NULL
©	NULL
WEAU	NULL
1	NULL
+3	NULL
%	NULL
AZT	NULL
e	NULL
th	NULL
#	NULL
@	NULL
-	NULL
0	NULL
T	NULL
T	NULL
T	NULL
T	NULL
10	NULL
4	NULL
6	NULL
8	NULL
10	NULL
6	NULL
8	NULL
days	NULL
after	NULL
infection	NULL
days	NULL
after	NULL
infection	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Kinetics	NULL
of	NULL
polyamide	NULL
inhibition	NULL
of	NULL
HIV-1	NULL
replication	NULL
and	NULL
effects	NULL
on	NULL
cell	NULL
viability	NULL
.	NULL

PBMC	NULL
were	NULL
infected	NULL
with	NULL
the	NULL
macrophage-tropic	NULL
HIV-1	NULL
isolate	NULL
SF162	NULL
(	NULL
4	NULL
and	NULL
B	NULL
)	NULL
or	NULL
the	NULL
T-cell	NULL
tropic	NULL
isolate	NULL
WEAU	NULL
1.6	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Polyamides	NULL
1	NULL
and	NULL
3	NULL
were	NULL
added	NULL
in	NULL
combination	NULL
at	NULL
1	NULL
uM	NULL
each	NULL
.	NULL

Virus	NULL
replication	NULL
was	NULL
monitored	NULL
by	NULL
p24	NULL
ELISA	NULL
(	NULL
4	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
polyamides	NULL
or	NULL
azidothymidine	NULL
(	NULL
B	NULL
and	NULL
D	NULL
)	NULL
.	NULL

cellular	NULL
genes	NULL
involved	NULL
in	NULL
T-cell	NULL
activation	NULL
could	NULL
have	NULL
an	NULL
indirect	NULL
effect	NULL
on	NULL
HIV-1	NULL
replication	NULL
.	NULL

To	NULL
assess	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
performed	NULL
an	NULL
RNase	NULL
protection	NULL
assay	NULL
for	NULL
transcripts	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cytokine	NULL
and	NULL
growth	NULL
factor	NULL
genes	NULL
,	NULL
including	NULL
interleukin	NULL
2	NULL
,	NULL
interleukin	NULL
5	NULL
,	NULL
and	NULL
interleukin	NULL
13	NULL
,	NULL
which	NULL
differ	NULL
in	NULL
the	NULL
target	NULL
sequences	NULL
flanking	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

Four	NULL
other	NULL
cytokine	NULL
genes	NULL
that	NULL
lack	NULL
binding	NULL
sites	NULL
for	NULL
either	NULL
polyamide	NULL
1	NULL
or	NULL
3	NULL
in	NULL
their	NULL
promoters	NULL
also	NULL
were	NULL
examined	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
exposure	NULL
of	NULL
activated	NULL
human	NULL
PBMC	NULL
to	NULL
a	NULL
combination	NULL
of	NULL
either	NULL
polyamides	NULL
1	NULL
+	NULL
3	NULL
or	NULL
2	NULL
+	NULL
4	NULL
(	NULL
1	NULL
wM	NULL
each	NULL
)	NULL
for	NULL
6	NULL
days	NULL
failed	NULL
to	NULL
inhibit	NULL
RNA	NULL
expression	NULL
of	NULL
all	NULL
of	NULL
the	NULL
genes	NULL
examined	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
difference	NULL
in	NULL
the	NULL
intensity	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
RNA	NULL
bands	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
equivalent	NULL
recovery	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
T	NULL
cells	NULL
in	NULL
treated	NULL
and	NULL
untreated	NULL
cells	NULL
.	NULL

This	NULL
lack	NULL
of	NULL
inhibition	NULL
of	NULL
cytokine	NULL
gene	NULL
transcription	NULL
suggests	NULL
that	NULL
the	NULL
polyamides	NULL
reduce	NULL
virus	NULL
replication	NULL
in	NULL
cells	NULL
by	NULL
a	NULL
direct	NULL
effect	NULL
on	NULL
HIV-1	NULL
RNA	NULL
transcription	NULL
.	NULL

Future	NULL
Plans	NULL
.	NULL

Our	NULL
present	NULL
studies	NULL
show	NULL
that	NULL
polyamides	NULL
designed	NULL
to	NULL
target	NULL
DNA	NULL
sequences	NULL
6-7	NULL
bp	NULL
in	NULL
length	NULL
are	NULL
effective	NULL
inhibitors	NULL
of	NULL
gene	NULL
transcription	NULL
in	NULL
cell-free	NULL
systems	NULL
and	NULL
viral	NULL
replication	NULL
in	NULL
human	NULL
cells	NULL
.	NULL

Because	NULL
sequences	NULL
of	NULL
these	NULL
lengths	NULL
would	NULL
be	NULL
highly	NULL
redundant	NULL
in	NULL
the	NULL
human	NULL
genome	NULL
,	NULL
it	NULL
had	NULL
seemed	NULL
likely	NULL
that	NULL
these	NULL
ligands	NULL
would	NULL
have	NULL
deleterious	NULL
effects	NULL
on	NULL
cell	NULL
metabolism	NULL
because	NULL
of	NULL
interference	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
cellular	NULL
genes	NULL
.	NULL

However	NULL
,	NULL
the	NULL
results	NULL
described	NULL
here	NULL
indicate	NULL
that	NULL
a	NULL
set	NULL
of	NULL
two	NULL
polyamides	NULL
that	NULL
recognize	NULL
6-	NULL
to	NULL
7-bp	NULL
sequences	NULL
can	NULL
be	NULL
sufficient	NULL
for	NULL
gene-specific	NULL
regulation	NULL
in	NULL
vivo	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
gene	NULL
sequence	NULL
flanking	NULL
TATA	NULL
region	NULL
HIV-1	NULL
5-TCCTCCATATAAGCAGCTGCT-3	NULL
'	NULL
IL-5	NULL
5-TGAGAGTTTTTAACCATTACA-3	NULL
'	NULL
IL-2	NULL
5-TTAACAGTATAAATTGCATCT-3	NULL
'	NULL
IL-13	NULL
5-TTGGGCCTATAAAAGCTGCCA-3	NULL
'	NULL
TNF-	NULL
5-AGGGACATATAAAGGCAGTTG-3	NULL
'	NULL
TGF-B	NULL
5-GGGGCTGTATTTAAGGACACC-3	NULL
'	NULL
GM-CSF	NULL
5-CTCTGTGTATTTAAGAGCTCT-3	NULL
'	NULL
TNF-B	NULL
5-CCTCCTCTATAAAGGGACCTG-3	NULL
'	NULL
MK	NULL
no	NULL
poiyamide	NULL
[	NULL
]	NULL
polyamides	NULL
1+3	NULL
Q	NULL
polyamides	NULL
2+4	NULL
IL-13	NULL
ID	NULL
cytokine	NULL
Tors	NULL
-P	NULL
GM-CSF	NULL
TNF	NULL
B	NULL
4	NULL
e	NULL
e	NULL
e	NULL
n	NULL
o	NULL
n	NULL
n	NULL
a	NULL
a	NULL
e	NULL
o	NULL
al	NULL
dt	NULL
cdt	NULL
al	NULL
0.01	NULL
0.1	NULL
1	NULL
10	NULL
100	NULL
Y	NULL
%	NULL
oL32	NULL
control	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Control	NULL
gene	NULL
expression	NULL
.	NULL

(	NULL
4	NULL
)	NULL
The	NULL
TATA	NULL
box	NULL
(	NULL
bold	NULL
)	NULL
and	NULL
flanking	NULL
sequences	NULL
(	NULL
from	NULL
GenBank	NULL
listings	NULL
)	NULL
of	NULL
each	NULL
of	NULL
the	NULL
cytokine/	NULL
growth	NULL
factor	NULL
genes	NULL
examined	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
polyamide	NULL
1	NULL
binding	NULL
site	NULL
is	NULL
underlined	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Ribonuclease	NULL
protection	NULL
assays	NULL
for	NULL
the	NULL
indicated	NULL
mRNAs	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

PBMCs	NULL
were	NULL
cultured	NULL
and	NULL
either	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
wM	NULL
polyamides	NULL
1	NULL
+	NULL
3	NULL
or	NULL
2	NULL
+	NULL
4	NULL
for	NULL
six	NULL
days	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
intensity	NULL
of	NULL
each	NULL
RNA	NULL
relative	NULL
to	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
ribosomal	NULL
L32	NULL
RNA	NULL
band	NULL
to	NULL
standardize	NULL
for	NULL
RNA	NULL
loading	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
compare	NULL
these	NULL
small	NULL
molecule	NULL
transcription	NULL
repressors	NULL
to	NULL
eukaryotic	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
that	NULL
also	NULL
recognize	NULL
multiple	NULL
short	NULL
sequences	NULL
to	NULL
increase	NULL
functional	NULL
specificity	NULL
(	NULL
27	NULL
,	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

The	NULL
observations	NULL
that	NULL
polyamides	NULL
do	NULL
not	NULL
interfere	NULL
with	NULL
pol	NULL
II	NULL
elongation	NULL
,	NULL
and	NULL
that	NULL
polyamides	NULL
can	NULL
bind	NULL
simultaneously	NULL
with	NULL
certain	NULL
major	NULL
groove	NULL
proteins	NULL
,	NULL
should	NULL
further	NULL
enhance	NULL
gene-specificity	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
polyamides	NULL
are	NULL
not	NULL
limited	NULL
to	NULL
6-	NULL
to	NULL
7-bp	NULL
recognition	NULL
.	NULL

For	NULL
example	NULL
,	NULL
polyamides	NULL
of	NULL
similar	NULL
size	NULL
to	NULL
those	NULL
described	NULL
here	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
as	NULL
cooperative	NULL
dimers	NULL
to	NULL
sites	NULL
10-16	NULL
bp	NULL
in	NULL
length	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
.	NULL

The	NULL
polyamide	NULL
binding	NULL
site	NULL
size	NULL
required	NULL
to	NULL
elicit	NULL
optimal	NULL
biological	NULL
function	NULL
should	NULL
be	NULL
reported	NULL
in	NULL
due	NULL
course	NULL
.	NULL

The	NULL
specific	NULL
inhibition	NULL
of	NULL
genes	NULL
transcribed	NULL
by	NULL
pol	NULL
II	NULL
represents	NULL
an	NULL
important	NULL
first	NULL
step	NULL
toward	NULL
asking	NULL
whether	NULL
cell-permeable	NULL
small	NULL
molecule	NULL
transcription	NULL
antagonists	NULL
might	NULL
regulate	NULL
gene	NULL
expression	NULL
in	NULL
complex	NULL
organisms	NULL
(	NULL
8	NULL
)	NULL
.	NULL

We	NULL
have	NULL
chosen	NULL
TBP	NULL
and	NULL
two	NULL
additional	NULL
key	NULL
regulators	NULL
of	NULL
HIV-1	NULL
transcription	NULL
,	NULL
Ets-1	NULL
and	NULL
LEF-1	NULL
,	NULL
as	NULL
targets	NULL
for	NULL
inhibition	NULL
of	NULL
pol	NULL
II-driven	NULL
transcription	NULL
.	NULL

Because	NULL
most	NULL
tissue-specific	NULL
cellular	NULL
genes	NULL
and	NULL
viral	NULL
genes	NULL
contain	NULL
TATA	NULL
elements	NULL
as	NULL
well	NULL
as	NULL
enhancer	NULL
factor	NULL
binding	NULL
sites	NULL
,	NULL
this	NULL
approach	NULL
may	NULL
be	NULL
generally	NULL
applicable	NULL
for	NULL
the	NULL
inhibition	NULL
of	NULL
most	NULL
target	NULL
genes	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
for	NULL
grants	NULL
to	NULL
P.B.D	NULL
,	NULL
J.M.G	NULL
.	NULL

,	NULL
and	NULL
D.E.M	NULL
.	NULL

for	NULL
research	NULL
support	NULL
,	NULL
the	NULL
National	NULL
Science	NULL
Foundation	NULL
and	NULL
the	NULL
Ralph	NULL
M.	NULL
Parsons	NULL
Foundation	NULL
for	NULL
predoctoral	NULL
Biochemistry	NULL
:	NULL
Dickinson	NULL
et	NULL
al	NULL
.	NULL

fellowships	NULL
to	NULL
J.W.T	NULL
.	NULL

,	NULL
and	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
for	NULL
a	NULL
predoctoral	NULL
fellowship	NULL
to	NULL
E.E.B	NULL
.	NULL

1	NULL
.	NULL

2	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

Wade	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Mrksich	NULL
,	NULL
M.	NULL
&	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Am	NULL
.	NULL

Chem	NULL
.	NULL

Soc	NULL
.	NULL

114	NULL
,	NULL
8784-8794	NULL
.	NULL

Mrksich	NULL
,	NULL
M.	NULL
,	NULL
Wade	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Dwyer	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Geierstanger	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
Wemmer	NULL
,	NULL
D.	NULL
E.	NULL
&	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
7586-7590	NULL
.	NULL

White	NULL
,	NULL
S.	NULL
,	NULL
Szewezyk	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Turner	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Baird	NULL
,	NULL
E.	NULL
E.	NULL
&	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
391	NULL
,	NULL
468-471	NULL
.	NULL

White	NULL
,	NULL
S.	NULL
,	NULL
Baird	NULL
,	NULL
E.	NULL
E.	NULL
&	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Chem	NULL
.	NULL

Biol	NULL
.	NULL

4	NULL
,	NULL
569-578	NULL
.	NULL

Pelton	NULL
,	NULL
J.	NULL
G.	NULL
&	NULL
Wemmer	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
5723-5727	NULL
.	NULL

Kielkopf	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Baird	NULL
,	NULL
E.	NULL
E.	NULL
,	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

&	NULL
Rees	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
Nat	NULL
.	NULL

Struct	NULL
.	NULL

Biol	NULL
.	NULL

5	NULL
,	NULL
104-109	NULL
.	NULL

Trauger	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Baird	NULL
,	NULL
E.	NULL
E.	NULL
&	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
382	NULL
,	NULL
559-561	NULL
.	NULL

Gottesfeld	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Neely	NULL
,	NULL
L.	NULL
,	NULL
Trauger	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Baird	NULL
,	NULL
E.	NULL
E.	NULL
&	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
387	NULL
,	NULL
202-205	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

&	NULL
Peterlin	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

63	NULL
,	NULL
717-1743	NULL
.	NULL

Travis	NULL
,	NULL
A.	NULL
,	NULL
Amsterdam	NULL
,	NULL
A.	NULL
,	NULL
Belanger	NULL
,	NULL
C.	NULL
&	NULL
Grossched1	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
880-894	NULL
.	NULL

Donaldson	NULL
,	NULL
L.	NULL
W.	NULL
,	NULL
Petersen	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Graves	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

&	NULL
McIntosh	NULL
,	NULL
L.	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
125-134	NULL
.	NULL

Kodandapani	NULL
,	NULL
R.	NULL
,	NULL
Pio	NULL
,	NULL
F.	NULL
,	NULL
Ni	NULL
,	NULL
C.-Z	NULL
.	NULL

,	NULL
Piccialli	NULL
,	NULL
G.	NULL
,	NULL
Klemsz	NULL
,	NULL
M.	NULL
,	NULL
McKercher	NULL
,	NULL
S.	NULL
,	NULL
Maki	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

&	NULL
Ely	NULL
,	NULL
K.	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
380	NULL
,	NULL
456-460	NULL
.	NULL

Baird	NULL
,	NULL
E.	NULL
E.	NULL
&	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J	NULL
.	NULL

Am	NULL
.	NULL

Chem	NULL
.	NULL

Soc	NULL
.	NULL

118	NULL
,	NULL
6141-6146	NULL
.	NULL

Love	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Li	NULL
,	NULL
X.	NULL
,	NULL
Case	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Glese	NULL
,	NULL
K.	NULL
,	NULL
Grosschedl	NULL
,	NULL
R.	NULL
&	NULL
Wright	NULL
,	NULL
P.	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
376	NULL
,	NULL
791-795	NULL
.	NULL

Sheridan	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Sheline	NULL
,	NULL
C.	NULL
T.	NULL
,	NULL
Cannon	NULL
,	NULL
K.	NULL
,	NULL
Voz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Pazin	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
&	NULL
Jones	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
2090-2104	NULL
.	NULL

Petersen	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Skalicky	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Donaldson	NULL
,	NULL
L.	NULL
W.	NULL
,	NULL
McIntosh	NULL
,	NULL
L.	NULL
P.	NULL
,	NULL
Alber	NULL
,	NULL
T.	NULL
&	NULL
Graves	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Science	NULL
269	NULL
,	NULL
1866-1869	NULL
.	NULL

Long	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Leresche	NULL
,	NULL
A.	NULL
,	NULL
Kriwacki	NULL
,	NULL
R.	NULL
W.	NULL
&	NULL
Gottesfeld	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
1467-1476	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Martin	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Shastry	NULL
,	NULL
B.	NULL
S.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

101	NULL
,	NULL
582-598	NULL
.	NULL

Lee	NULL
,	NULL
G.	NULL
,	NULL
Wu	NULL
,	NULL
J.	NULL
,	NULL
Luu	NULL
,	NULL
P.	NULL
,	NULL
Ghazal	NULL
,	NULL
P.	NULL
&	NULL
Flores	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Nail	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
,	NULL
2570-2574	NULL
.	NULL

Mosier	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Gulizia	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Baird	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Wilson	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Spector	NULL
,	NULL
D.	NULL
H.	NULL
&	NULL
Spector	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
251	NULL
,	NULL
791-794	NULL
.	NULL

Mosier	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Gulizia	NULL
,	NULL
R.	NULL
,	NULL
Maclsaac	NULL
,	NULL
P.	NULL
,	NULL
Torbett	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Levy	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
260	NULL
,	NULL
689-692	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
-	NULL
12895	NULL
Estable	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Bell	NULL
,	NULL
B.	NULL
,	NULL
Merzouki	NULL
,	NULL
A.	NULL
,	NULL
Montaner	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
O'Shaughnessy	NULL
,	NULL
M.	NULL
V.	NULL
&	NULL
Sadowski	NULL
,	NULL
I.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

70	NULL
,	NULL
4053-4062	NULL
.	NULL

Frech	NULL
,	NULL
K.	NULL
,	NULL
Brack-Werner	NULL
,	NULL
R.	NULL
&	NULL
Werner	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Virology	NULL
224	NULL
,	NULL
256-267	NULL
.	NULL

Trauger	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Baird	NULL
,	NULL
E.	NULL
E.	NULL
,	NULL
Mrksich	NULL
,	NULL
M.	NULL
&	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J	NULL
.	NULL

Am	NULL
.	NULL

Chem	NULL
.	NULL

Soc	NULL
.	NULL

118	NULL
,	NULL
6160-6166	NULL
.	NULL

Kim	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Nikolov	NULL
,	NULL
D.	NULL
B	NULL
.	NULL

&	NULL
Burley	NULL
,	NULL
S.	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
365	NULL
,	NULL
520-527	NULL
.	NULL

Kim	NULL
,	NULL
Y.	NULL
,	NULL
Geiger	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Hahn	NULL
,	NULL
S.	NULL
&	NULL
Sigler	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
365	NULL
,	NULL
512-520	NULL
.	NULL

Burley	NULL
,	NULL
S.	NULL
K.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

65	NULL
,	NULL
769-699	NULL
.	NULL

Kim	NULL
,	NULL
J.	NULL
,	NULL
Gonzales-Scarano	NULL
,	NULL
F.	NULL
,	NULL
Zeichner	NULL
,	NULL
S.	NULL
&	NULL
Alwine	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Virol	NULL
67	NULL
,	NULL
1658-1662	NULL
.	NULL

Klotman	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Kim	NULL
,	NULL
S.	NULL
,	NULL
Buchbinder	NULL
,	NULL
A.	NULL
,	NULL
DeRossi	NULL
,	NULL
A.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
&	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Nail	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
5011-5015	NULL
.	NULL

Clark	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Saag	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Decker	NULL
,	NULL
W.	NULL
D.	NULL
,	NULL
Campbell-Hill	NULL
,	NULL
S.	NULL
,	NULL
Roberson	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Veldkamp	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Kappes	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Hahn	NULL
,	NULL
B.	NULL
H.	NULL
&	NULL
Shaw	NULL
,	NULL
G.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

324	NULL
,	NULL
954-960	NULL
.	NULL

Borrow	NULL
,	NULL
P.	NULL
,	NULL
Lewicki	NULL
,	NULL
H.	NULL
,	NULL
Wei	NULL
,	NULL
X.	NULL
,	NULL
Horwitz	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Peffer	NULL
,	NULL
N.	NULL
,	NULL
Meyers	NULL
,	NULL
H.	NULL
,	NULL
Nelson	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Gairin	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Hahn	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
Oldstone	NULL
,	NULL
M.	NULL
B.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Nat	NULL
.	NULL

Med	NULL
.	NULL

3	NULL
,	NULL
205-211	NULL
.	NULL

Cheng-Mayer	NULL
,	NULL
C.	NULL
,	NULL
Seto	NULL
,	NULL
D.	NULL
,	NULL
Tateno	NULL
,	NULL
M.	NULL
&	NULL
Levy	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Science	NULL
240	NULL
,	NULL
80-82	NULL
.	NULL

Cheng-Mayer	NULL
,	NULL
C.	NULL
,	NULL
Weiss	NULL
,	NULL
C.	NULL
,	NULL
Seto	NULL
,	NULL
D.	NULL
&	NULL
Levy	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
8575-8579	NULL
.	NULL

Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

21	NULL
,	NULL
327-335	NULL
.	NULL

Verrijzer	NULL
,	NULL
C.	NULL
P.	NULL
&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

21	NULL
,	NULL
328-342	NULL
.	NULL

Oakley	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Mrksich	NULL
,	NULL
M.	NULL
&	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Biochemistry	NULL
31	NULL
,	NULL
10969-10975	NULL
.	NULL

Trauger	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Baird	NULL
,	NULL
E.	NULL
E.	NULL
&	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J	NULL
.	NULL

Am	NULL
.	NULL

Chem	NULL
.	NULL

Soc	NULL
.	NULL

120	NULL
,	NULL
3534-3535	NULL
.	NULL

Trauger	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Baird	NULL
,	NULL
E.	NULL
E.	NULL
&	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Angew	NULL
.	NULL

Chem	NULL
.	NULL

Int	NULL
.	NULL

Ed	NULL
.	NULL

Engl	NULL
.	NULL

37	NULL
,	NULL
1421-1423	NULL
.	NULL

Batchelor	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
Piper	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
de	NULL
la	NULL
Brousse	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
&	NULL
Wolberger	NULL
,	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
Science	NULL
279	NULL
,	NULL
1037-1041	NULL
.	NULL

Nye	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Petersen	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Gunther	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
Jonsen	NULL
,	NULL
M.	NULL
D.	NULL
&	NULL
Graves	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
975-990	NULL
.	NULL

Hobbs	NULL
,	NULL
M.	NULL
V.	NULL
,	NULL
Weigle	NULL
,	NULL
W.	NULL
O.	NULL
,	NULL
Noonan	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Torbett	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
McEvilly	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Koch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Cardenas	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

&	NULL
Ernst	NULL
,	NULL
D.	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

150	NULL
,	NULL
3602-3614	NULL
.	NULL

Rochford	NULL
,	NULL
R.	NULL
,	NULL
Miller	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Cannon	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Izumi	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Kieff	NULL
,	NULL
E.	NULL
&	NULL
Longnecker	NULL
,	NULL
R.	NULL
(	NULL
1997	NULL
)	NULL
Arch	NULL
.	NULL

Virol	NULL
.	NULL

142	NULL
,	NULL
707-720	NULL
.	NULL

